Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

NeuralSTEM receives patent protection for CNS stem cell technology

May 25, 1998

New agents for schizophrenia from Meiji Seika

May 25, 1998

Caspase inhibitor demonstrates neuroprotective properties in rats

May 25, 1998

The acetylcholinesterase inhibitor rivastigmine demonstrates neuroprotective potential

May 25, 1998

Eisai seeks collaborators for development of novel antipsychotic

May 22, 1998

Forest's antidepressant drug is approvable

May 22, 1998

Investigators discover clues to the functions of apoE

May 22, 1998

Selective dopamine D3 receptor ligands developed at Neurogen

May 22, 1998

Fiblast North American stroke trial suspended

May 21, 1998

IRFI-165, an adenosine antagonist for the treatment of depression

May 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Other news to note for July 27, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Abbvie, Genmab, Merck, Par, Thyora.